Navigation Links
PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,,,Demonstrate Safety and Efficacy at Once-Weekly Dosing

tic peptides, is creating long-acting compounds based on bioconjugation platform technologies. When applied to peptides, the Company's systemic DAC(TM) and PC-DAC(TM) Technologies enable the creation of new drugs with significantly enhanced therapeutic properties as compared to the original peptide. Detailed descriptions of the Company can be viewed on the Company's website www.conjuchem.com.

Forward-Looking Statements

Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause ConjuChem's actual results, performance or achievements to be materially different from those expressed or implied by any of the Company's statements. Actual events or results may differ materially. We disclaim any intention, and assume no obligation, to update these forward-looking statements.

%SEDAR: 00023748EF

-30-

/For further information: Lennie Ryer, CA, Vice President, Finance & CFO, ConjuChem Biotechnologies Inc., (514) 844-5558 ext 224, ryer@conjuchem.com; Michael Polonsky, Investor Relations, (416) 815-0700 ext. 231, (416) 815-0080, mpolonsky@equicomgroup.com/


'"/>




Page: 1 2 3 4

Related medicine technology :

1. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/23/2009)... LINCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc...reproductsintheemergencymedicalservices(EMS)andres...urexecutivestoitsseniormanagementteam.Thenewexecut...DonnaHill,executivevicepresidentandgeneralcounsel;...egRobitaille,executivevicepresidentofcorporatedeve...
(Date:11/23/2009)... SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-FirstC...tDr.TedW.LoveandDr.DavidC.U,Prichardhaveagreedtojo...heproposedmergerbetweenAnesivaandArcionTherapeutic...scheduledtotakeplaceatthepreviouslyannouncedAnesiv...r3,2009at9:00a.m.PSTat400OysterPoint,Suite107A,Sou...
(Date:11/23/2009)... ALISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCall/--O...icals International(NYSE: VRX ),todayannouncedthat...idiniumbromide,anauthorizedgeneric(AG)versionofLib...ectstobeasignificantplayerintheLibrax®generic...portantdivisionofourU.S.businesswithitssuccessfull...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Health Integrated Named to the 2009 Inc 5000 54478 1Health Integrated Named to the 2009 Inc 5000 54478 2First human gene implicated in regulating length of human sleep 9568 1First human gene implicated in regulating length of human sleep 9568 2First human gene implicated in regulating length of human sleep 9568 3Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 1Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 2Queen of Soul Foods Grandson on Mission to Get Harlem Kids to Eat Healthier 54472 3
...ar Therapeutics present preliminary Phase II data ... intubated and mechanically-ven...er HealthCare,together with Nektar Therapeutics (N...ry Phase II data on their unique drug-device combi...ciety (ATS) annual meeting. Amikacin,Inhale, curre...
...ria Holdings, Inc., a fully,integrated critical ca...t,has completed dosing of its Phase 1a trial for i...jection., The study was a Phase 1, randomized, si...escalation study of a single bolus injection of IK...rability and pharmacokinetics.,The study comprised...
Other Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3
(Date:11/23/2009)...related protein changes offer clues to treatment a... (HealthDay News) -- The protein content of saliva...f these changes may help lead to a simple test to ...rs suggest. , Human saliva contains numerous pr...eases and other functions. Researchers are trying ...
(Date:11/23/2009)...e generation of new nerve cells in the brain is re...affects the stem cells, maturation into nerve cell...erve cells through the brain tissue, reveals new r...the journal Stem Cells . , Although the researc...ls, it could lead to a new medicine for human bein...
(Date:11/23/2009)...acksburg, Va. The United States Department of Agr...rant to Virginia Tech and the University of Minnes...ticated turkey, Meleagris gallopavo. The funding w...tium to complete the genome sequencing using next-...me sequence, and identify genes and functions in t...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire-FirstCall/--AnnTaylo...syearasapartnerforthe6thannualThanksandGivingcampa...deChildren,sResearchHospital.Thisyearmarksthethird...nginitiative,hasparticipatedinthecampaignwhereweof...esbysupportingSt.Judewhileshoppingthisholidayseaso...
(Date:11/23/2009)..., NEWORLEANS,Nov.23/PRNewswire/--Thanksgivingwee...Stronginitstradition,theClassicrepresentsthesports...ameforthecityofNewOrleansandthoseinattendance. ,...he,thisisachanceforsomedowntimebeforetheyworktotes...ftertwoyearsofconstruction,PettyOfficerClaudeBovel...
Breaking Medicine News(10 mins):Health News:Turkey Genome Sequencing Consortium awarded $0.9 million from USDA 2Health News:Ann Taylor Stores Corp. Returns To St. Jude Children's Research Hospital's Thanks and Giving Campaign(R) For The Third Year 2Health News:Nothing Is Like Being There 2
... The flu virus infecting humans has not been id...ere in the world. , , , , The Centers ... "At this time, there is no evidence that this inf...nce to indicate that any of the human illnesses re...
...Speaker Nancy Pelosi issued the following statemen...r Kathleen Sebelius to serve as the next Health an... Governor Kathleen Sebelius on her confirmation by...eded as the nation confronts the public health eme...
...t of Kansas Governor,s Record of Patients First an... , , WASHINGTON, April 28 Kidney Care Partners,...sionals, care providers and manufacturers working ...e U.S. Department of Health and Human Services. ...
...and attorneys from around the country handling tho...k on June 3 for a conference and webcast on effect...ng a better understanding of asbestos trusts. , ,... chairmen are Perry Weitz of Weitz & Luxenberg...
...organizers of a massive community-wide event offer...derinsured and un-insured originally planned for t...Area Medical), ramohio.org, the group behind the e... the spreading threat of swine flu infection. , ,...
...lth Care Reform Assures Strong Leadership for Offi...m , , WASHINGTON, April 28 The National Patient ...t organization dedicated to the mission of creatin...ansas Governor Kathleen Sebelius as Secretary of H...
Other Medicine News:Health News:National Pork Board Provides Facts About the Origin of the Flu Outbreak 2Health News:Kidney Care Partners Applauds Governor Sebelius's Appointment as U.S. Secretary of Health and Human Services 2Health News:Asbestos Judges, Attorneys Holding Judicial Forum June 3 2Health News:RAM Ohio Free Medical Clinic Cancelled Due to Swine Flu Outbreak 2Health News:National Patient Advocate Foundation Applauds Confirmation of Governor Sebelius as Secretary of Health and Human Services 2
...rity Series is a cost-effective, versatile pulse o...ECG, pace detect/reject, digital oximetry with SAC...ion. A high-resolution electroluminescent screen ... optional recorder (Smiths Medical PM, Inc. catalo...
... was designed with the sleep environment in mind. ...of CO 2 and SpO 2 in one affordable unit, and ca... sleep studies. This next generation system utili...metry technology for reliable SpO 2 measurements,...
... is a Windows based, easy-to-use software for use ...r. Using the Smiths Medical PM, Inc. catalog #338...n collected during sleep screening, oxygen therapy...n the Clinician's interpretation by analyzing SpO ...
...ration refractive multifocal IOL that provides hyp... from glasses than monofocal IOLs. The ReZoom prop...on that monfocals cannot match. , ,The ReZoom ...over five optic zones so that each lens has a dist...
Medicine Products: